Atossa Therapeutics, Inc. logo

ATOSAtossa Therapeutics, Inc.

ATOS Stock Price, Valuation & Chart | Atossa Therapeutics, Inc.

Compare

ATOS Historical price chart

ATOS Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Market Capitalization24.54M
PE Ratio-0.57
EPS-4.3
Trading Volume44.77K
Today's High/Low2.51/2.44
Dividend Yield0.00
52 Week High/Low19.35/1.7
Shares Outstanding9.97M
ATOS Financial Statement
ATOS Analyst ratings
ATOS Analysis & performance metrics

ATOS Company profile

Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases.…

ATOS Management team

Management
Richard Graydon M.D., Ph.D.
Interim Chief Medical Officer
Delly Behen P.H.R.
Senior Vice President of Business Operations
Steven C. Quay FCAP, M.D., Ph.D.CEO
Chairman, Chief Executive Officer & President
Heather Rees CPACFO
Chief Financial Officer
Michael Parks
Vice President of Investor & Public Relations
Total 5 executives

ATOS Frequently asked questions

What is Atossa Therapeutics, Inc. (ATOS) Stock Price?

Current stock price of Atossa Therapeutics, Inc. (ATOS) stock is $2.460. The stock price is +1.65% higher in the session. The intraday range can be seen from this page. Volume of Atossa Therapeutics, Inc. (ATOS) stock is 44.77K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Atossa Therapeutics, Inc. (ATOS) stock price going up or down today?

The stock price of Atossa Therapeutics, Inc. (ATOS) can change with earnings, company news, and overall market sentiment. Atossa Therapeutics, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Atossa Therapeutics, Inc. stock expensive at its current price?

Whether Atossa Therapeutics, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for ATOS on this page is -0.57. EPS on this page is -4.30. Compare those figures with peers and growth expectations before deciding if the current Atossa Therapeutics, Inc. price is justified.

How has the stock price of Atossa Therapeutics, Inc. (ATOS) performed historically?

Historical performance for Atossa Therapeutics, Inc. (ATOS) is shown on the price chart on this page. Review multi-period moves alongside volume to see how ATOS reacted to past earnings and market events.

Should I buy Atossa Therapeutics, Inc. (ATOS) stock, at this price?

Buying Atossa Therapeutics, Inc. (ATOS) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.